TY - JOUR AU - Ayala, G. AU - Tuxhorn, J. A. AU - Wheeler, T. M. AU - Frolov, A. AU - Scardino, P. T. AU - Ohori, M. AU - Wheeler, M. AU - Spitler, J. AU - Rowley, D. R. PY - 2003 DA - 2003// TI - Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer JO - Clin Cancer Res VL - 9 ID - Ayala2003 ER - TY - JOUR AU - Valcz, G. AU - Sipos, F. AU - Tulassay, Z. AU - Molnar, B. AU - Yagi, Y. PY - 2014 DA - 2014// TI - Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology JO - J Clin Pathol VL - 67 UR - https://doi.org/10.1136/jclinpath-2014-202561 DO - 10.1136/jclinpath-2014-202561 ID - Valcz2014 ER - TY - JOUR AU - Augsten, M. PY - 2014 DA - 2014// TI - Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment JO - Frontiers Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00062 DO - 10.3389/fonc.2014.00062 ID - Augsten2014 ER - TY - JOUR AU - Paraiso, K. H. AU - Smalley, K. S. PY - 2013 DA - 2013// TI - Fibroblast-mediated drug resistance in cancer JO - Biochem Pharmacol VL - 85 UR - https://doi.org/10.1016/j.bcp.2013.01.018 DO - 10.1016/j.bcp.2013.01.018 ID - Paraiso2013 ER - TY - JOUR AU - Li, G. AU - Satyamoorthy, K. AU - Herlyn, M. PY - 2001 DA - 2001// TI - N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells JO - Cancer Res VL - 61 ID - Li2001 ER - TY - JOUR AU - Choe, C. AU - Shin, Y. S. AU - Kim, S. H. AU - Jeon, M. J. AU - Choi, S. J. AU - Lee, J. AU - Kim, J. PY - 2013 DA - 2013// TI - Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway JO - Anticancer Res VL - 33 ID - Choe2013 ER - TY - JOUR AU - Lee, K. W. AU - Everett, T. H. AU - Rahmutula, D. AU - Guerra, J. M. AU - Wilson, E. AU - Ding, C. AU - Olgin, J. E. PY - 2006 DA - 2006// TI - Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure JO - Circulation VL - 114 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.624320 DO - 10.1161/CIRCULATIONAHA.106.624320 ID - Lee2006 ER - TY - JOUR AU - Nguyen, D. T. AU - Ding, C. AU - Wilson, E. AU - Marcus, G. M. AU - Olgin, J. E. PY - 2010 DA - 2010// TI - Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias JO - Heart Rhythm VL - 7 UR - https://doi.org/10.1016/j.hrthm.2010.04.030 DO - 10.1016/j.hrthm.2010.04.030 ID - Nguyen2010 ER - TY - JOUR AU - Oku, H. AU - Shimizu, T. AU - Kawabata, T. AU - Nagira, M. AU - Hikita, I. AU - Ueyama, A. AU - Matsushima, S. AU - Torii, M. AU - Arimura, A. PY - 2008 DA - 2008// TI - Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis JO - Eur J Pharmacol VL - 590 UR - https://doi.org/10.1016/j.ejphar.2008.06.046 DO - 10.1016/j.ejphar.2008.06.046 ID - Oku2008 ER - TY - JOUR AU - King, T. E. AU - Bradford, W. Z. AU - Castro-Bernardini, S. AU - Fagan, E. A. AU - Glaspole, I. AU - Glassberg, M. K. AU - Gorina, E. AU - Hopkins, P. M. AU - Kardatzke, D. AU - Lancaster, L. PY - 2014 DA - 2014// TI - A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402582 DO - 10.1056/NEJMoa1402582 ID - King2014 ER - TY - JOUR AU - Lin, X. AU - Yu, M. AU - Wu, K. AU - Yuan, H. AU - Zhong, H. PY - 2009 DA - 2009// TI - Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon’s fibroblasts in vitro JO - Invest Ophthalmol Vis Sci VL - 50 UR - https://doi.org/10.1167/iovs.08-2815 DO - 10.1167/iovs.08-2815 ID - Lin2009 ER - TY - JOUR AU - Shi, Q. AU - Liu, X. AU - Bai, Y. AU - Cui, C. AU - Li, J. AU - Li, Y. AU - Hu, S. AU - Wei, Y. PY - 2011 DA - 2011// TI - In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0028134 DO - 10.1371/journal.pone.0028134 ID - Shi2011 ER - TY - JOUR AU - Lee, B. S. AU - Margolin, S. B. AU - Nowak, R. A. PY - 1998 DA - 1998// TI - Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production JO - J Clin Endocrinol Metab VL - 83 UR - https://doi.org/10.1210/jcem.83.1.4503 DO - 10.1210/jcem.83.1.4503 ID - Lee1998 ER - TY - JOUR AU - Dosanjh, A. K. AU - Wan, B. AU - Throndset, W. AU - Sherwood, S. AU - Morris, R. E. PY - 1998 DA - 1998// TI - Pirfenidone: a novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis JO - Transplant Proceed VL - 30 UR - https://doi.org/10.1016/S0041-1345(98)00478-3 DO - 10.1016/S0041-1345(98)00478-3 ID - Dosanjh1998 ER - TY - JOUR AU - Kozono, S. AU - Ohuchida, K. AU - Eguchi, D. AU - Ikenaga, N. AU - Fujiwara, K. AU - Cui, L. AU - Mizumoto, K. AU - Tanaka, M. PY - 2013 DA - 2013// TI - Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-3180 DO - 10.1158/0008-5472.CAN-12-3180 ID - Kozono2013 ER - TY - JOUR AU - Yang, Y. AU - Ye, Y. AU - Lin, X. AU - Wu, K. AU - Yu, M. PY - 2013 DA - 2013// TI - Inhibition of pirfenidone on TGF-beta2 induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04 JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0056837 DO - 10.1371/journal.pone.0056837 ID - Yang2013 ER - TY - JOUR AU - Hisatomi, K. AU - Mukae, H. AU - Sakamoto, N. AU - Ishimatsu, Y. AU - Kakugawa, T. AU - Hara, S. AU - Fujita, H. AU - Nakamichi, S. AU - Oku, H. AU - Urata, Y. PY - 2012 DA - 2012// TI - Pirfenidone inhibits TGF-beta1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells JO - BMC Pulmonary Med VL - 12 UR - https://doi.org/10.1186/1471-2466-12-24 DO - 10.1186/1471-2466-12-24 ID - Hisatomi2012 ER - TY - JOUR AU - Cottin, V. PY - 2013 DA - 2013// TI - The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis JO - Resp Res VL - 14 Suppl 1 ID - Cottin2013 ER - TY - JOUR AU - Choi, Y. H. AU - Back, K. O. AU - Kim, H. J. AU - Lee, S. Y. AU - Kook, K. H. PY - 2013 DA - 2013// TI - Pirfenidone attenuates IL-1beta-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-kappaB activity JO - Exp Eye Res VL - 113 UR - https://doi.org/10.1016/j.exer.2013.05.001 DO - 10.1016/j.exer.2013.05.001 ID - Choi2013 ER - TY - JOUR AU - Rose, M. C. AU - Kostyanovskaya, E. AU - Huang, R. S. PY - 2014 DA - 2014// TI - Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer JO - Genom Proteom Bioinform VL - 12 UR - https://doi.org/10.1016/j.gpb.2014.10.003 DO - 10.1016/j.gpb.2014.10.003 ID - Rose2014 ER - TY - JOUR AU - Yin, J. Y. AU - Huang, Q. AU - Zhao, Y. C. AU - Zhou, H. H. AU - Liu, Z. Q. PY - 2012 DA - 2012// TI - Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0038150 DO - 10.1371/journal.pone.0038150 ID - Yin2012 ER - TY - JOUR AU - Rabik, C. A. AU - Dolan, M. E. PY - 2007 DA - 2007// TI - Molecular mechanisms of resistance and toxicity associated with platinating agents JO - Cancer Treat Rev VL - 33 UR - https://doi.org/10.1016/j.ctrv.2006.09.006 DO - 10.1016/j.ctrv.2006.09.006 ID - Rabik2007 ER - TY - JOUR AU - Sonnenberg, M. AU - Kuip, H. AU - Haubeis, S. AU - Fritz, P. AU - Schroth, W. AU - Friedel, G. AU - Simon, W. AU - Murdter, T. E. AU - Aulitzky, W. E. PY - 2008 DA - 2008// TI - Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast JO - BMC Cancer VL - 8 UR - https://doi.org/10.1186/1471-2407-8-364 DO - 10.1186/1471-2407-8-364 ID - Sonnenberg2008 ER - TY - JOUR AU - Mediavilla-Varela, M. AU - Luddy, K. AU - Noyes, D. AU - Khalil, F. K. AU - Neuger, A. M. AU - Soliman, H. AU - Antonia, S. J. PY - 2013 DA - 2013// TI - Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth JO - Cancer Biol Ther VL - 14 UR - https://doi.org/10.4161/cbt.25643 DO - 10.4161/cbt.25643 ID - Mediavilla-Varela2013 ER - TY - JOUR AU - Chou, T. C. PY - 2006 DA - 2006// TI - Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies JO - Pharmacol Rev VL - 58 UR - https://doi.org/10.1124/pr.58.3.10 DO - 10.1124/pr.58.3.10 ID - Chou2006 ER - TY - JOUR AU - Burghardt, I. AU - Tritschler, F. AU - Opitz, C. A. AU - Frank, B. AU - Weller, M. AU - Wick, W. PY - 2007 DA - 2007// TI - Pirfenidone inhibits TGF-beta expression in malignant glioma cells JO - Biochem Biophys Res Commun VL - 354 UR - https://doi.org/10.1016/j.bbrc.2007.01.012 DO - 10.1016/j.bbrc.2007.01.012 ID - Burghardt2007 ER - TY - JOUR AU - Iyer, S. N. AU - Hyde, D. M. AU - Giri, S. N. PY - 2000 DA - 2000// TI - Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation JO - Inflammation VL - 24 UR - https://doi.org/10.1023/A:1007068313370 DO - 10.1023/A:1007068313370 ID - Iyer2000 ER - TY - JOUR AU - Wang, J. AU - Yang, Y. AU - Xu, J. AU - Lin, X. AU - Wu, K. AU - Yu, M. PY - 2013 DA - 2013// TI - Pirfenidone inhibits migration, differentiation, and proliferation of human retinal pigment epithelial cells in vitro JO - Molec Vision VL - 19 ID - Wang2013 ER - TY - STD TI - Choi SH, Nam JK, Jang J, Lee HJ, Lee YJ. Pirfenidone enhances the efficacy of combined radiation and sunitinib therapy. Biochem Biophys Res Commun. 2015. In press. ID - ref29 ER -